GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.940
+0.270 (5.78%)
At close: Mar 5, 2025, 4:00 PM
5.05
+0.11 (2.13%)
After-hours: Mar 5, 2025, 7:51 PM EST
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 8.75, with a low estimate of 6.00 and a high estimate of 16. The average target predicts an increase of 77.13% from the current stock price of 4.94.
Analyst Consensus: Buy
* Price targets were last updated on Jan 10, 2025.
Analyst Ratings
The average analyst rating for GoodRx Holdings stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Hold | 6 | 6 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 16 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.25 | Strong Buy | Maintains | $7 → $6.25 | +26.52% | Jan 10, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +21.46% | Jan 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +21.46% | Dec 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +41.70% | Nov 13, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +21.46% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
842.09M
from 792.32M
Increased by 6.28%
Revenue Next Year
901.66M
from 842.09M
Increased by 7.07%
EPS This Year
0.41
from 0.04
Increased by 918.37%
EPS Next Year
0.49
from 0.41
Increased by 20.54%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 886.1M | 963.3M | 1.0B | ||
| Avg | 842.1M | 901.7M | 982.7M | ||
| Low | 797.5M | 829.8M | 892.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.8% | 14.4% | 16.3% | ||
| Avg | 6.3% | 7.1% | 9.0% | ||
| Low | 0.7% | -1.5% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.49 | 0.62 | 0.70 | |
| Avg | 0.41 | 0.49 | 0.59 | |
| Low | 0.34 | 0.41 | 0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1,133.8% | 52.1% | 43.3% | |
| Avg | 918.4% | 20.5% | 21.2% | |
| Low | 757.5% | 1.0% | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.